Ortho Regenerative Technologies said its chief scientific officer, Michael Buschmann, has been appointed as bioengineering chair, professor and eminent scholar (an award from Virginia’s Center for Innovative...
Ortho Regenerative Technologies appointed François-Xavier Lacasse to the newly created position of VP of product development. Dr. Lacasse’s mandate will be development and execution of a comprehensive product...
Microbix Biosystems (TSX:MBX) has appointed Cameron Groome as its president and CEO, with Vaughn Embro-Pantalony retiring from those positions but remaining an executive director, working closely with Mr. Groome to...
Cantor Fitzgerald expanded its healthcare equity research team with the additions of Louise Chen and Travis Steed. Ms. Chen is joining Cantor as a senior research analyst and managing director, focused on specialty...